Company · Ownership research

Cryoport, Inc. CYRX

CIK 0001124524

Form 4 transactions dated Nov 1, 2023 to Nov 8, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 56 rows; the complete set is available through the API.

Insider filings on file run through Aug 11, 2026.

Insider purchases & sales

Purchased: $0.00
Sold: $11.42M

Nov 1, 2023 – Aug 11, 2026
Available records · partial months are marked ·

202510 of 26 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 10, 2025	Mandalam Ramkumar Director	Sale	$115.54K 11,570 shares sold	12.53% sold Direct holding	▾
Sep 11, 2025	Hariri Robert J Director	Sale	$242.74K 25,000 shares sold	32.78% sold Direct holding	▾
Aug 22, 2025	Hariri Robert J Director	Sale	$43.00K 5,000 shares sold	15.99% sold Direct holding	▾
Aug 19, 2025	STEFANOVICH ROBERT Chief Financial Officer	Sale	$80.62K 9,300 shares sold	4.30% sold Direct holding	▾
Jul 22, 2025	Mandalam Ramkumar Director	Sale	$294.90K 40,728 shares sold	30.61% sold Direct holding	▾
Jun 24, 2025	SHELTON JERRELL President, CEO · Director	Sale	$115.37K 16,344 shares sold	1.76% sold Direct holding	▾
Jun 24, 2025	Mandalam Ramkumar Director	Sale	$93.45K 13,321 shares sold	15.42% sold Direct holding	▾
Jun 20, 2025	SHELTON JERRELL President, CEO · Director	Sale	$447.52K 69,135 shares sold	7.04% sold Direct holding	▾
Jun 18, 2025	SHELTON JERRELL President, CEO · Director	Sale	$812.54K 119,281 shares sold	11.56% sold Direct holding	▾
Jun 17, 2025	SHELTON JERRELL President, CEO · Director	Sale	$1.03M 151,304 shares sold	14.22% sold Direct holding	▾

Showing 26 / 26 record groups in 2025. The complete set is available through the API.

Cryoport, Inc. · CYRX

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 26 of 26 purchase / sale groups and 30 of 56 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"CYRX","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.